Influence of HMG-CoA Reductase Inhibitors on Leptin-Induced Endothelial Cell Proliferation, Migration, and Capillary-Like Tube Formation

References

• . Bjørbaek C. Central leptin receptor action and resistance in obesity. J Invest Med. 2009;57(7):789–794
   PubMed Web of Science ®Google Scholar
• . Stejskal D, RůRzicka V, Bartek J. Serum leptin, early atherosclerosis and hypolipidemia (a new, previously undescribed effect of pravastatin, a hypolipemic agent). Vnitr Lek. 1998;44(10):582–587
   PubMedGoogle Scholar
• . Nicklas BJ, Katzel LI, Ryan AS, Dennis KE, Goldberg AP. Gender differences in the response of plasma leptin concentrations to weight loss in obese older individuals. Obes Res. 1997;5(1):62–68
   PubMedGoogle Scholar
• . Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763–770
   PubMed Web of Science ®Google Scholar
• . Gannagé-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol. 2006;155(1):167–176
   PubMedGoogle Scholar
• . Söderberg S, Ahrén B, Jansson JH, . Leptin is associated with increased risk of myocardial infarction. J Intern Med. 1999;246(4):409–418
   PubMedGoogle Scholar
• . Schäfer K, Halle M, Goeschen C, . Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol. 2004;24(1):112–117
   PubMedGoogle Scholar
• . Loffreda S, Yang SQ, Lin HZ, . Leptin regulates proinflammatory immune responses. FASEB J. 1998;12(1):57–65
   PubMed Web of Science ®Google Scholar
• . Sommer G, Kralisch S, Stangl V, Vietzke A, Köhler U, Stepan H. Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem. 2009;106(4):729–737
   PubMedGoogle Scholar
• . Knudson JD, Payne GA, Borbouse L, Tune JD. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep. 2008;10(6):434–439
   PubMed Web of Science ®Google Scholar
• . Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res. 2005;126(1):121–129
   PubMedGoogle Scholar
• . Rahmouni K, Haynes WG. Endothelial effects of leptin: implications in health and diseases. Curr Diab Rep. 2005;5(4):260–266
   PubMedGoogle Scholar
• . Schaefer CA, Kuhlmann CR, Weiterer S, Fehsecke A, Abdallah Y, Schaefer C. Statins inhibit hypoxia-induced endothelial proliferation by preventing calcium-induced ROS formation. Atherosclerosis. 2006;185(2):290–296
   PubMedGoogle Scholar
• . Park HY, Kwon HM, Lim HJ, . Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 2001;33(2):95–102
   PubMed Web of Science ®Google Scholar
• . Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA. 2002;287(13):1706–1709
   PubMed Web of Science ®Google Scholar
• . Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes. 1999;48(2):426–429
   PubMed Web of Science ®Google Scholar
• . Konstantinides S, Schäfer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001;108(10):1533–1540
   PubMed Web of Science ®Google Scholar
• . Glomset JA, Gelb MH, Farnsworth CC. Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci. 1990;15(4):139–142
   PubMedGoogle Scholar
• . Maltese WA. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 1990;4(15):3319–3328
   PubMedGoogle Scholar
• . Cox AD, Der CJ. Ras history: The saga continues. Small GTPases. 2010;1(1):2–27
   PubMedGoogle Scholar
• . Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev. 1997;11(18):2295–2322
   PubMed Web of Science ®Google Scholar
• . Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998;273(37):24266–24271
   PubMed Web of Science ®Google Scholar
• . Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279(5350):509–514
   PubMed Web of Science ®Google Scholar
• . Balk EM, Lau J, Goudas LC, . Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med. 2003;139(8):670–682
   PubMedGoogle Scholar
• . Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84(24):9265–9269
   PubMed Web of Science ®Google Scholar
• . Calabrò P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol. 2005;20(6):541–546
   PubMed Web of Science ®Google Scholar
• . Heeba G, Moselhy ME, Hassan M, Khalifa M, Gryglewski R, Malinski T. Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. Br J Pharmacol. 2009;156(8):1256–1266
   PubMedGoogle Scholar
• . Settergren M, Böhm F, Rydén L, Pernow J. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J. 2008;29(14):1753–1760
   PubMedGoogle Scholar
• . Zhu XY, Daghini E, Chade AR, . Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci. 2008;83(23–24):801–809
   PubMed Web of Science ®Google Scholar
• . Yokoyama K, Ishibashi T, Ohkawara H, . HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation. 2002;105(8):962–967
   PubMedGoogle Scholar
• . Barenholz Y. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. Subcell Biochem. 2004;37:167–215
   PubMedGoogle Scholar
• . Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002;110(5):597–603
   PubMed Web of Science ®Google Scholar
• . Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1(1):31–39
   PubMed Web of Science ®Google Scholar
• . Siekmann TR, Burgazli KM, Bobrich MA, Nöll G, Erdogan A. The antiproliferative effect of pinostrobin on human umbilical vein endothelial cells (HUVEC). Eur Rev Med Pharmacol Sci. 2013;17(5):668–672
   PubMedGoogle Scholar
• . Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745–2756
   PubMed Web of Science ®Google Scholar
• . Korff T, Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol. 1998;143(5):1341–1352
   PubMedGoogle Scholar
• . Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999;13(10):1231–1238
   PubMed Web of Science ®Google Scholar
• . Dubey L, Zeng HS, Wang HJ, Liu RY. Potential role of adipocytokine leptin in acute coronary syndrome. Asian Cardiovasc Thorac Ann. 2008;16(2):124–128
   PubMedGoogle Scholar
• . Garonna E, Botham KM, Birdsey GM, Randi AM, Gonzalez-Perez RR, Wheeler-Jones CP. Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells. PLoS One. 2011;6(4):e18823
   Google Scholar
• . Goetze S, Bungenstock A, Czupalla C, . Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension. 2002;40(5):748–754
   PubMed Web of Science ®Google Scholar
• . Nath AK, Brown RM, Michaud M, Sierra-Honigmann MR, Snyder M, Madri JA. Leptin affects endocardial cushion formation by modulating EMT and migration via Akt signaling cascades. J Cell Biol. 2008;181(2):367–380
   PubMedGoogle Scholar
• . Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation. 2002;105(6):739–745
   PubMed Web of Science ®Google Scholar
• . Katsumoto M, Shingu T, Kuwashima R, Nakata A, Nomura S, Chayama K. Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis. Circ J. 2005;69(12):1547–1555
   PubMed Web of Science ®Google Scholar
• . Maeda T, Horiuchi N. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation. J Biochem. 2009;145(6):771–781
   PubMed Web of Science ®Google Scholar
• . Korda M, Kubant R, Patton S, Malinski T. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol. 2008;295(4):1514–1521
   Google Scholar
• . Dje N Guessan P, Riediger F, Vardarova K, . Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. Arterioscler Thromb Vasc Biol. 2009;29(3):380–386
   PubMedGoogle Scholar
• . Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89–118
   PubMed Web of Science ®Google Scholar
• . Vincent L, Chen W, Hong L, . Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett. 2001;495(3):159–166
   PubMed Web of Science ®Google Scholar
• . Park SY, Lee JS, Ko YJ, . Inhibitory effect of simvastatin on the TNF-alpha- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation. Arch Pharm Res. 2008;31(2):195–204
   PubMedGoogle Scholar
• . Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny TV. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg. 2001;88(7):945–950
   PubMedGoogle Scholar
• . Hayden MR, Tyagi SC. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol. 2004;3:1
   PubMedGoogle Scholar
• . Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92(3):657–671
   PubMed Web of Science ®Google Scholar
• . Liao JK. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002;86(1):5–18
   PubMedGoogle Scholar
• . Vaughan CJ, Gotto AM Jr, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35(1):1–10
   PubMed Web of Science ®Google Scholar
• . Waters DD. What the statin trials have taught us. Am J Cardiol. 2006;98(1):129–134
   PubMedGoogle Scholar
• . Bouloumié A, Drexler HC, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83(10):1059–1066
   PubMed Web of Science ®Google Scholar
• . Kureishi Y, Luo Z, Shiojima I, . The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6(9):1004–1010
   PubMed Web of Science ®Google Scholar
• . Khaidakov M, Wang W, Khan JA, Kang BY, Hermonat PL, Mehta JL. Statins and angiogenesis: is it about connections? Biochem Biophys Res Commun. 2009;387(3):543–547
   PubMed Web of Science ®Google Scholar
• . Sata M, Nishimatsu H, Suzuki E, . Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J. 2001;15(13):2530–2532
   PubMedGoogle Scholar
• . Zeidan A, Javadov S, Chakrabarti S, Karmazyn M. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res. 2008;77(1):64–72
   PubMed Web of Science ®Google Scholar